Company Overview and News

1
Japan’s Renesas to buy US chipmaker IDT for US$6.7bil

2018-09-12 thestar.com.my - 1
TOKYO: Japanese chipmaker Renesas Electronics Corp said it had agreed to buy US peer Integrated Device Technology (IDT) Inc for about US$6.7bil, aiming to boost its expertise in self-driving car technologies.
MEL ISIL MIELY 6501 6503 6723 RNECF MIELF IDTI RNECY HTHIY

2
Japan's Renesas to buy US chipmaker IDT for US$6.7 billion

2018-09-11 channelnewsasia
Japanese chipmaker Renesas Electronics Corp said on Tuesday it had agreed to buy U.S. peer Integrated Device Technology Inc for about US$6.7 billion, as it aims to compete with Nvidia and Intel Corp in self-driving car technologies.
MEL ISIL MIELY 6501 6503 6723 RNECF MIELF IDTI RNECY INTC HTHIY

15
Under visionary Shigenobu Nagamori, precision motor-maker Nidec sees EVs driving future profits

2018-09-10 japantimes.co.jp
KYOTO – Since starting Nidec in 1973 in a tiny Kyoto shed with just three workers, Shigenobu Nagamori has built it into the world’s top maker of precision motors and became one of Japan’s most venerated business leaders.
GEC GE 6501 TM 7203 TYT GNE SFTBF 9984 TOYOF HTHIY SFTBY

16
Japan's Nidec sees electric vehicles driving profits as it plans for future

2018-09-07 theedgemarkets - 1
KYOTO, Japan (Sep 7): Since starting Nidec in 1973 in a tiny Kyoto shed with just three workers, Shigenobu Nagamori has built it into the world’s top maker of precision motors and became one of Japan’s most venerated business leaders.
GEC GE 6501 TM 7203 TYT GNE SFTBF 9984 TOYOF HTHIY SFTBY

15
Japan's Nidec sees electric vehicles driving profits as it plans for future

2018-09-07 reuters
KYOTO, Japan (Reuters) - Since starting Nidec in 1973 in a tiny Kyoto shed with just three workers, Shigenobu Nagamori has built it into the world’s top maker of precision motors and became one of Japan’s most venerated business leaders.
GEC GE 6501 TM 7203 TYT GNE SFTBF 9984 TOYOF HTHIY SFTBY

 
JR Tokai sets up unit in Texas with eye on orders for the state’s bullet train project

2018-09-05 japantimes.co.jp
NAGOYA – Central Japan Railway Co. (JR Tokai), has set up a wholly owned subsidiary in Dallas in an effort to win orders related to a project to build a high-speed railway in Texas.
9022 MHVYF 6501 HTHIY 7011

5
INCJ raked in ¥769.4 billion in nine years, 2.4 times more than amount it invested

2018-09-01 japantimes.co.jp
Innovation Network Corp. of Japan (INCJ) has said that the government-backed investment fund collected ¥769.4 billion in the nine years from its 2009 launch to the end of March this year, 2.4 times more than the amount it invested.
6501 JNNDF 6740 JPDYY SNE SNEJF HTHIY

 
Japan’s Renesas Electronics in talks to acquire U.S. semiconductor maker IDT

2018-08-31 japantimes.co.jp
Japanese chipmaker Renesas Electronics Corp. is in talks to acquire U.S. peer Integrated Device Technology Inc. for around $5.5 billion, sources said Friday.
MEL ISIL MIELY 6501 6503 6723 RNECF MIELF IDTI RNECY HTHIY

 
Drones offer high-tech help to Japan's ageing farmers

2018-08-23 channelnewsasia
For several months, developers and farmers in northeast Japan have been testing a new drone that can hover above paddy fields and perform backbreaking tasks in a fraction of the time it takes for elderly farmers.
6501 SSUMF HTHIY

 
Hitachi picks U.S. engineering firm Bechtel to manage U.K. nuclear plant project

2018-08-23 japantimes.co.jp
Hitachi Ltd. has appointed major U.S. engineering giant Bechtel Corp. as the project management contractor for a nuclear power plant it plans to build in Britain.
6501 HTHIY

 
Japanese firms in talks over alliance on nuclear power: sources

2018-08-22 japantimes.co.jp
Two major utilities and a pair of power plant manufacturers are considering a four-way alliance on nuclear power operations, sources said Wednesday, as the industry grapples with rising costs related to decommissioning and safety.
6501 TKECF CHUEF 9501 TKECY HTHIY

 
Japan's Daikin, thriving in Asia and India, sets sights on Africa

2018-08-21 reuters
TOKYO (Reuters) - Daikin Industries, (6367.T) the world’s largest maker of air conditioning equipment, is turning to Africa for further expansion, 10 years after a successful gamble on sharing its key technology with a Chinese company.
PCRFY DKILF DKILY 6501 BC94 SMSN UTX 6367 HTHIY SMSD

 
Japan's Daikin, thriving in Asia and India, sets sights on Africa

2018-08-21 channelnewsasia
Daikin Industries, the world's largest maker of air conditioning equipment, is turning to Africa for further expansion, 10 years after a successful gamble on sharing its key technology with a Chinese company.
PCRFY DKILF DKILY 6501 BC94 SMSN UTX 6367 HTHIY SMSD

 
Is Conglomerate Sector a Spent Force or One to Reckon With?

2018-08-20 zacks
Second-quarter results have been quite impressive for majority of the U.S. equity sectors. Of the major stock indexes, the S&P 500 has gained 4.8% since the start of July while the NYSE has rallied 3.2%. Impressive corporate results for the quarter were one of the main driving forces behind the stock markets rallies. Of the 16 Zacks sectors, Conglomerates was one of the two sectors that recorded a decline in second-quarter earnings, the other being Auto/Tires/Trucks.
6501 FSS CSL HTHIY

 
Hitachi to launch AI analysis of hospital leftovers to hasten inpatient recovery

2018-08-20 japantimes.co.jp
A unit of Hitachi Ltd. will launch a new venture that uses artificial intelligence to analyze the leftovers of carefully planned hospital meals to ensure patients get the nutrients needed to better facilitate recovery, company officials said Monday.
6501 HTHIY

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...